Home > Riviste > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Fascicoli precedenti > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2020 March;64(1) > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2020 March;64(1):85-95

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo

 

ORIGINAL ARTICLE   

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2020 March;64(1):85-95

DOI: 10.23736/S1824-4785.19.03040-1

Copyright © 2019 EDIZIONI MINERVA MEDICA

lingua: Inglese

Is 99mTc-HMPAO-leukocyte imaging an accurate method in evaluating therapy result in prosthetic joint infection and diagnosing suspected chronic prosthetic joint infection?

Johan TEILER 1, 2 , Marcus AHL 3, 4, Börje ÅKERLUND 3, 4, Sara WIRD 5, Harald BRISMAR 1, 6, Annie BJÄREBACK 7, Håkan HEDLUND 1, 8, Maria HOLSTENSSON 7, Rimma AXELSSON 1, 7

1 Department of Clinical Science, Technique and Intervention (CLINTEC), Karolinska Institute, Stockholm, Sweden; 2 Abdominal Radiology, Karolinska University Hospital, Huddinge, Sweden; 3 Department of Medicine, Karolinska Institute, Stockholm, Sweden; 4 Unit of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden; 5 Department of Pediatric Radiology, Karolinska University Hospital, Stockholm, Sweden; 6 Department of Orthopedic Surgery, Karolinska University Hospital, Stockholm, Sweden; 7 Department of Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden; 8 Department of Orthopedic Surgery, Visby General Hospital, Visby, Sweden



BACKGROUND: To investigate the sensitivity and specificity of 99mTc-HMPAO-leukocyte imaging in evaluating therapy result in patients with prosthetic joint infection (PJI) and in diagnosing suspected chronic PJI.
METHODS: Sixty-two patients (63 joints) with microbiologically verified PJI were examined by leukocyte imaging to evaluate therapy result during or at the end of antibiotic treatment or if the patient had a chronic PJI after treatment. Group 1 consisted of 49 patients with on-going or within less than 14 days of ending antibiotic treatment examined to evaluate response. Group 2 consisted of 13 patients examined after completed treatment on suspicion of chronic PJI with no or recently initiated renewed antibiotic treatment. This study applied a combination of different imaging approaches of 99mTc-HMPAO-leukocyte scintigraphy: delayed and late planar images, bone marrow imaging and SPECT/CT imaging. All joints were examined with at least two of the approaches and 53 joints with all three approaches. The report was based on the combined results of the approaches used. A chronic PJI was confirmed with a positive microbiological culture. A cured infection was confirmed with either a negative culture or at least 24 months antibiotic-free follow-up with no relapse.
RESULTS: In the therapy evaluation group sensitivity was 0.57 and specificity was 0.81. In the suspected chronic infection group sensitivity was 1.00 and specificity 0.91.
CONCLUSIONS: 99mTc-HMPAO-leukocyte imaging appears to be an accurate method to diagnose or exclude chronic PJI, but cannot be recommended for therapy evaluation of PJI in patients with on-going antibiotic treatment.


KEY WORDS: Leukocytes; Imaging; Single photon emission computed tomography computed tomography; Infection; Arthroplasty

inizio pagina